Evaluation of interleukin-35 and interleukin-10 in adult acute myeloid leukemia patients before and after induction chemotherapy
BACKGROUND: Acute myeloid leukemia (AML) is a clonal proliferation of hemopoietic cells. Interleukin-35 (IL-35) is a pro-inflammatory cytokine expressed in T regulatory (Treg) and B regulatory cells. IL-35 promotes the proliferation of AML blasts and lessens apoptosis. Hence, IL-35-derived from Treg...
Main Authors: | Eman Fadhil Mahmood, Abeer Anwer Ahmed |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Iraqi Journal of Hematology |
Subjects: | |
Online Access: | http://www.ijhonline.org/article.asp?issn=2072-8069;year=2020;volume=9;issue=2;spage=82;epage=86;aulast=Mahmood |
Similar Items
-
The Role, Involvement and Function(s) of Interleukin-35 and Interleukin-37 in Disease Pathogenesis
by: Ramatu Omenesa Bello, et al.
Published: (2018-04-01) -
Interleukin-35 on B cell and T cell induction and regulation
by: Ai Huang, et al.
Published: (2017-08-01) -
Cytokines profiling as prognostic markers in newly diagnosed acute myeloid leukemia
by: Hiba Shakir Ahmed, et al.
Published: (2017-01-01) -
Interleukin-27 and interleukin-35 in de novo acute myeloid leukemia: expression and significance as biological markers
by: Ahmed HA, et al.
Published: (2019-10-01) -
Prognostic values of β2 microglobulin, interleukin-4, and interleukin-6 in patients with different stages of chronic lymphocytic leukemia
by: Intisar Shakir Ali, et al.
Published: (2020-01-01)